in vitro News and Research

RSS

Oncodesign receives AAALAC certification for Dijon-based research center

Oncodesign, a contract research laboratory for the discovery of new anticancer therapies, today announces that its Dijon-based research center has received AAALAC certification.

18 Jul 2013

CHOP-led research increases numbers of patients who could be treated with gene therapy

Gene therapy researchers have produced a bioengineered decoy that fools the immune system and prevents it from mistakenly defeating the benefits delivered by a corrective gene.

18 Jul 2013

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Scientists at the University of Massachusetts Medical School are the first to establish that a naturally occurring X chromosome "off switch" can be rerouted to neutralize the extra chromosome responsible for trisomy 21, also known as Down syndrome, a genetic disorder characterized by cognitive impairment.

18 Jul 2013

State highlights: Poll says N.C. abortion bill hurting Governor support

A selection of health policy stories from North Carolina, California and Virginia.

18 Jul 2013

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.

18 Jul 2013

North Dakota judge strikes down state law on nonsurgical abortion drugs

The state judge issues an opinion from an April trial. In the meantime, new abortion and "personhood" proposals in that state rankle some medical professionals.

17 Jul 2013

Study explores mechanisms of chemotherapy-induced neurological side effects

Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, including vascular complications, seizures, mood disorders, cognitive dysfunctions, and peripheral neuropathies.

16 Jul 2013

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Semi-quantitative pregnancy tests: an interview with Dr. Paul Blumenthal, Stanford University School of Medicine

Regular pregnancy tests work a little bit like a simple light switch that you have on your wall. It’s either on or off. When it’s on, that means the test is positive; if it’s off, obviously, it’s negative.

12 Jul 2013

UC Riverside professor receives grant to study potential treatment for age-related macular degeneration

A University of California, Riverside bioengineering professor has received a two-year, $120,000 grant to search for chemical compounds that have the potential to treat age-related macular degeneration.

12 Jul 2013

PrenaTest can be now performed for high risk pregnancies after ninth week

PrenaTest, Europe's first non-invasive molecular genetic blood test to determine fetal trisomies 13, 18 and 21 in the mother's blood can now be performed for high risk pregnancies after the ninth week (W 9 + D 0).

11 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

A new low-cost method of in-vitro fertilization developed at the University of Colorado Boulder that performed successfully in recent human clinical trials in Belgium may help thousands of infertile couples in developing countries.

9 Jul 2013

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, announced today the publication of pre-clinical data for VB-201 in the journal of Atherosclerosis.

8 Jul 2013

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.

8 Jul 2013

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer's Association International Conference in Boston, MA July 13 - 18, 2013.

8 Jul 2013

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

Blood Cell Storage, Inc., a leading medical device provider based in Seattle, WA and ORIGIO a/s, a leader in delivering innovative Assisted Reproductive Technology solutions headquartered in Malov Denmark, announced a partnership today during the annual meeting of the European Society of Human Reproduction and Embryology.

8 Jul 2013

New research shows that exercise changes expression of innate DNA

Exercise, even in small doses, changes the expression of our innate DNA. New research from Lund University in Sweden has described for the first time what happens on an epigenetic level in fat cells when we undertake physical activity.

4 Jul 2013

Medical ethicists find no justification to support UK's legal ban on sex selection

As Europe's leading fertility specialists gather at a conference in London this weekend, a major new publication from leading medical ethicists finds no justification to support the UK's legal ban on sex selection before pregnancy for 'social' reasons.

3 Jul 2013

Study: IVF treatment linked with increased risk of mental retardation

In a study that included more than 2.5 million children born in Sweden, compared with spontaneous conception, any in vitro fertilization (IVF) treatment was not associated with autistic disorder but was associated with a small but statistically significantly increased risk of mental retardation, according to a study in the July 3 issue of JAMA. The authors note that the prevalence of these disorders was low, and the increase in absolute risk associated with IVF was small.

3 Jul 2013

in vitro News and Research

Oncodesign receives AAALAC certification for Dijon-based research center

CHOP-led research increases numbers of patients who could be treated with gene therapy

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

State highlights: Poll says N.C. abortion bill hurting Governor support

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

North Dakota judge strikes down state law on nonsurgical abortion drugs

Study explores mechanisms of chemotherapy-induced neurological side effects

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Semi-quantitative pregnancy tests: an interview with Dr. Paul Blumenthal, Stanford University School of Medicine

UC Riverside professor receives grant to study potential treatment for age-related macular degeneration

PrenaTest can be now performed for high risk pregnancies after ninth week

Cancer immunotherapies promise to be a new tool in fight against cancer

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

New research shows that exercise changes expression of innate DNA

Medical ethicists find no justification to support UK's legal ban on sex selection

Study: IVF treatment linked with increased risk of mental retardation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News